Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

March 1, 2011; Volume 52,Issue 3

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 11A-12A;

SNM Newsline

  • You have access
    Jobs and New Initiatives in Nuclear Medicine Education
    Jay A. Harolds, Robert A. Novelline, Milton J. Guiberteau, Darlene Metter and M. Elizabeth Oates
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 17N-23N;
  • You have access
    SNM Membership Categories Expanded; New Award
    Todd Peterson
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 23N;
  • You have access
    We Can't Control the Future, but We Can Plan for It
    Dominique Delbeke and George M. Segall
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 24N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 26N-27N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 28N-30N;

Focus on Molecular Imaging

  • You have access
    Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors
    Vincent Grégoire and Arturo Chiti
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 331-334; DOI: https://doi.org/10.2967/jnumed.110.075689

Invited Perspectives

  • You have access
    PET of αvβ3-Integrin and αvβ5-Integrin Expression with 18F-Fluciclatide for Assessment of Response to Targeted Therapy: Ready for Prime Time?
    Ambros J. Beer and Markus Schwaiger
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 335-337; DOI: https://doi.org/10.2967/jnumed.110.078568
  • You have access
    Avoiding Barriers to PET Radioligand Development: Cellular Assays of Brain Efflux Transporters
    Matthew D. Hall and Victor W. Pike
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 338-340; DOI: https://doi.org/10.2967/jnumed.110.081125

Clinical Investigations

  • You have access
    Preliminary Study of 11C-Choline PET/CT for T Staging of Locally Advanced Nasopharyngeal Carcinoma: Comparison with 18F-FDG PET/CT
    Hu-bing Wu, Quan-shi Wang, Ming-fang Wang, Xiaokang Zhen, Wen-lan Zhou and Hong-sheng Li
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 341-346; DOI: https://doi.org/10.2967/jnumed.110.081190
  • You have access
    Improvement in Lesion Detection with Whole-Body Oncologic Time-of-Flight PET
    Georges El Fakhri, Suleman Surti, Cathryn M. Trott, Joshua Scheuermann and Joel S. Karp
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 347-353; DOI: https://doi.org/10.2967/jnumed.110.080382
  • You have access
    Detection and Characterization of Tumor Changes in 18F-FDG PET Patient Monitoring Using Parametric Imaging
    Hatem Necib, Camilo Garcia, Antoine Wagner, Bruno Vanderlinden, Patrick Emonts, Alain Hendlisz, Patrick Flamen and Irène Buvat
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 354-361; DOI: https://doi.org/10.2967/jnumed.110.080150
  • You have access
    In Vivo Imaging of Mineral Deposition in Carotid Plaque Using 18F-Sodium Fluoride PET/CT: Correlation with Atherogenic Risk Factors
    Thorsten Derlin, Christian Wisotzki, Ulrich Richter, Ivayla Apostolova, Peter Bannas, Christoph Weber, Janos Mester and Susanne Klutmann
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 362-368; DOI: https://doi.org/10.2967/jnumed.110.081208
  • You have access
    Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
    Florent Tixier, Catherine Cheze Le Rest, Mathieu Hatt, Nidal Albarghach, Olivier Pradier, Jean-Philippe Metges, Laurent Corcos and Dimitris Visvikis
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 369-378; DOI: https://doi.org/10.2967/jnumed.110.082404
  • You have access
    Shortened Acquisition Protocols for the Quantitative Assessment of the 2-Tissue-Compartment Model Using Dynamic PET/CT 18F-FDG Studies
    Ludwig G. Strauss, Leyun Pan, Caixia Cheng, Uwe Haberkorn and Antonia Dimitrakopoulou-Strauss
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 379-385; DOI: https://doi.org/10.2967/jnumed.110.079798
  • You have access
    18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation
    Amanda F. Cashen, Farrokh Dehdashti, Jingqin Luo, Andrew Homb, Barry A. Siegel and Nancy L. Bartlett
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.110.082586
  • You have access
    Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B
    Philipp T. Meyer, Sabine Hellwig, Florian Amtage, Christof Rottenburger, Ursula Sahm, Peter Reuland, Wolfgang A. Weber and Michael Hüll
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 393-400; DOI: https://doi.org/10.2967/jnumed.110.083683

Brief Communications

  • You have access
    Observation of Glucose Metabolism in the Thalamic Nuclei by Fusion PET/MRI
    Zang-Hee Cho, Young-Don Son, Hang-Keun Kim, Nam-Beom Kim, Eun-Jung Choi, Sang-Yoon Lee, Je-Geun Chi, Chan-Woong Park, Young-Bo Kim and Seiji Ogawa
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 401-404; DOI: https://doi.org/10.2967/jnumed.110.081281

Continuing Education

  • You have access
    The Sentinel Node Procedure in Breast Cancer: Nuclear Medicine as the Starting Point
    Elif Hindié, David Groheux, Isabelle Brenot-Rossi, Domenico Rubello, Jean-Luc Moretti and Marc Espié
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 405-414; DOI: https://doi.org/10.2967/jnumed.110.081711

Erratum

  • You have access
    Errata
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 495;

Basic Science Investigations

  • You have access
    Transport of Selected PET Radiotracers by Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2): An In Vitro Screening
    Nicolas Tournier, Héric Valette, Marie-Anne Peyronneau, Wadad Saba, Sébastien Goutal, Bertrand Kuhnast, Frédéric Dollé, Jean-Michel Scherrmann, Salvatore Cisternino and Michel Bottlaender
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.110.079608
  • You have access
    Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled αVβ3-Integrin and αVβ5-Integrin Imaging Agent
    Mark R. Battle, Julian L. Goggi, Lucy Allen, Jon Barnett and Matthew S. Morrison
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.110.077479
  • You have access
    Total Abdominal 18F-FDG Uptake Reflects Intestinal Adenoma Burden in Apc Mutant Mice
    Dianne M. Heijink, Jan H. Kleibeuker, Wouter B. Nagengast, Dorenda Oosterhuis, Adrienne H. Brouwers, Jan J. Koornstra, Steven de Jong and Elisabeth G.E. de Vries
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 431-436; DOI: https://doi.org/10.2967/jnumed.110.083956
  • You have access
    18F-Fluromisonidazole PET Imaging as a Biomarker for the Response to 5,6-Dimethylxanthenone-4-Acetic Acid in Colorectal Xenograft Tumors
    Christoph Oehler, Joseph A. O'Donoghue, James Russell, Pat Zanzonico, Sylvie Lorenzen, C. Clifton Ling and Sean Carlin
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 437-444; DOI: https://doi.org/10.2967/jnumed.110.081372
  • You have access
    Recording Intracellular Molecular Events from the Outside: Glycosylphosphatidylinositol-Anchored Avidin as a Reporter Protein for In Vivo Imaging
    Steffi Lehmann, Elisa Garcia Garayoa, Alain Blanc, Ruth Keist, Roger Schibli and Markus Rudin
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 445-452; DOI: https://doi.org/10.2967/jnumed.110.082412
  • You have access
    Accuracy and Reproducibility of Absolute Quantification of Myocardial Focal Tracer Uptake from Molecularly Targeted SPECT/CT: A Canine Validation
    Yi-Hwa Liu, Zakir Sahul, Christopher A. Weyman, Donald P. Dione, Wawrzyniec L. Dobrucki, Choukri Mekkaoui, Matthew P. Brennan, William J. Ryder and Albert J. Sinusas
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 453-460; DOI: https://doi.org/10.2967/jnumed.110.082214
  • You have access
    Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
    Helena Wållberg, Anna Orlova, Mohammed Altai, Seyed Jalal Hosseinimehr, Charles Widström, Jennie Malmberg, Stefan Ståhl and Vladimir Tolmachev
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 461-469; DOI: https://doi.org/10.2967/jnumed.110.083592
  • You have access
    In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor–Expressing Prostate Cancer
    Kimberly A. Lears, Riccardo Ferdani, Kexian Liang, Alexander Zheleznyak, Rebecca Andrews, Christopher D. Sherman, Samuel Achilefu, Carolyn J. Anderson and Buck E. Rogers
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 470-477; DOI: https://doi.org/10.2967/jnumed.110.082826
  • You have access
    Micro-SPECT/CT–Based Pharmacokinetic Analysis of 99mTc-Diethylenetriaminepentaacetic Acid in Rats with Blood–Brain Barrier Disruption Induced by Focused Ultrasound
    Feng-Yi Yang, Hsin-Ell Wang, Guan-Liang Lin, Ming-Che Teng, Hui-Hsien Lin, Tai-Tong Wong and Ren-Shyan Liu
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 478-484; DOI: https://doi.org/10.2967/jnumed.110.083071
  • You have access
    Radiation Dosimetry of 82Rb in Humans Under Pharmacologic Stress
    Srinivasan Senthamizhchelvan, Paco E. Bravo, Martin A. Lodge, Jennifer Merrill, Frank M. Bengel and George Sgouros
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 485-491; DOI: https://doi.org/10.2967/jnumed.110.083477

Letters to the Editor

  • You have access
    Beta-cell Imaging: Opportunities and Limitations
    Thomas C. Kwee, Sandip Basu, Babak Saboury, Drew A. Torigian, Ali Naji and Abass Alavi
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 493; DOI: https://doi.org/10.2967/jnumed.110.085530
  • You have access
    Reply: Beta-cell Imaging: Opportunities and Limitations
    Masanori Ichise and Paul E. Harris
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 493-495; DOI: https://doi.org/10.2967/jnumed.110.086249

Book Review

  • You have access
    Clinical MR Spectroscopy: Techniques and Applications
    E. Edmund Kim
    Journal of Nuclear Medicine March 1, 2011, 52 (3) 492; DOI: https://doi.org/10.2967/jnumed.110.084830
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 52 (3)
Journal of Nuclear Medicine
Vol. 52, Issue 3
March 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • This Month in JNM
  • SNM Newsline
  • Focus on Molecular Imaging
  • Invited Perspectives
  • Clinical Investigations
  • Brief Communications
  • Continuing Education
  • Erratum
  • Basic Science Investigations
  • Letters to the Editor
  • Book Review
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire